41st Annual New Treatments in Chronic Liver Disease

New Treatments in Chronic Liver Disease will highlight the latest advancements in medications and therapies for liver care and transplantation. The program will offer an in-depth review of clinical trials and real-world data on oral treatments for chronic viral hepatitis B and C, non-alcoholic fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, hepatocellular carcinoma, and complications of end-stage liver disease, including thrombocytopenia. This annual CME conference delivers a comprehensive yet targeted program designed to provide physicians with the latest updates and practical insights for managing liver diseases.

1. Cite new strategies for identifying and managing metabolic liver disease.
2. Review updated goals and guidelines for curing Delta Hepatitis, HBV and HCV.
3. Discuss potential new treatments for alcohol-related liver disease.
4. Summarize novel markers and therapies in PBC and PSC.
5. Evaluate liver masses and new therapeutic options for HCC.
6. Employ strategies for treating and managing ascites and hepatorenal syndrome.

*Must use a valid Scripps email address when registering.

**To receive the student, resident, fellow registration discount code, please email or call Scripps CME and provide proof of your status.

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Scripps Health designates this activity for a maximum of 10.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

American Board of Internal Medicine
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Pathology
Successful completion of this CME activity enables the learner to earn 10.25 Lifelong Learning (CME) credit toward the CME requirement(s) of the American Board of Pathology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP credit.

Attendee Cancellation, Substitution and Refund
The course tuition is refundable, minus a $100 processing fee (MD, DO, RN, PA, NP) or a $50 processing fee (Students, Residents, Fellows), if your cancellation is received in writing no later than Friday, February 26, 2027. Attendee substitutions are allowed, but notification must be made in writing by Friday, February 26, 2027. After this date, under no circumstances will refunds, credits, or substitutions be granted. No refunds or credits will be given to “no shows.” No refunds shall be made for cancellations due to inclement weather.

Scripps Course Modification or Cancellation
Scripps reserves the right to modify the course’s schedule or program as necessary. Scripps also reserves the right to cancel this course, in which case a full refund of the registration fee will be provided. Attendees who purchase non-refundable airline tickets do so at their own risk. Scripps encourages the purchase of travel insurance as we are unable to refund any travel costs (flight, hotel, etc.) in the case of Scripps cancellation.

Recording and Photography Clause
Scripps reserves exclusive rights to record (audio and video) and/or photograph all course proceedings for use in marketing materials, presentations and course content sales.

Family and Guest Attendance Policy
All course activities and meals are exclusively reserved for paid course attendees. Children and family members are not allowed to attend meal functions or permitted in the meeting space.

Accessibility Statement
Scripps is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodation, including dietary concerns, please email [email protected].

The Seabird Ocean Resort
101 Mission Ave
Oceanside, California 92054
Reservations: 855-420-8163 (reference code G-LDM3 when booking)
Reserve a Discounted Room

Please make your own hotel reservations and request the Scripps course reduced rate of $339 per night (plus tax and parking). Make your reservations early! A block of rooms is being held for us at the special rate until Friday, February 19, 2027, or until the room block fills, whichever comes first. After this date, reservations will be accepted on a space and rate availability basis only. Attendees who book their room through an online, third-party service are not eligible for room block concessions including reduced resort fee and discounted overnight parking.

Travel Advisory
Please reserve your room using the link provided above or by contacting the hotel directly. If you receive an email from an organization claiming to be a third-party booking site and urging you to book rooms for the course through their service or link, avoid clicking any links in these emails or sharing any personal information with them. These emails are phishing attempts, and the organizations behind them are not associated with Scripps or the course hotel.

Mitigation of Relevant Financial Relationships

Disclosure of Relevant Financial Relationships and Content Validity

It is policy at Scripps Health’s Office of Continuing Medical Education (CME) for course directors, planners, moderators, faculty, and all others in a position to control content of an educational activity disclose all financial relationships with ineligible companies that they may have had within the past 24 months. This policy is in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. If an individual refuses to disclose financial relationships, they will be disqualified from being a part of the planning and implementation of the activity. Owners and/or employees of an ineligible company with business lines or products relating to the content of the activity will not be permitted to participate in the planning or execution of any accredited program.

The intent of this policy is to ensure that Scripps Health CME/CE certified activities promote quality and safety, are effective in improving medical practice, consist of valid, evidence-based content, and are independent of control from ineligible companies and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain any financial relationships. This process consisted of reviewing the content, determining which financial relationships were relevant, and applying appropriate mitigation strategies. All listed relevant financial relationships with ineligible companies for individuals in control of content have been mitigated prior to the commencement of the activity.

The staff in Scripps Health’s Office of Continuing Medical Education have disclosed that they have no financial relationships with any ineligible companies. Any peer reviewer who is determined to have a relevant financial relationship must recuse themselves from the peer review process.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Shannon Kennedy
Scripps Health
San Diego, CA

Activity Administrator

Nothing to disclose

Sarah Harding
Scripps Health
San Diego, CA

Activity Coordinator

Nothing to disclose

Julio A Gutierrez, MD
Scripps Clinic
La Jolla , CA

Activity/Course Director

Stocks or stock options, excluding diversified mutual funds-AKERO|Stocks or stock options, excluding diversified mutual funds-Novo Nordisk (Any division)|Other: DSMB-Escient|Other: DSMB-Surrozen|Honoraria-Ipsen Biopharmaceuticals, Inc.|Speakers Bureau-Viking|Honoraria-Alexion Pharmaceuticals|Honoraria-Intercept|Stocks or stock options, excluding diversified mutual funds-HepaTx|Stocks or stock options, excluding diversified mutual funds-DURECT|Stocks or stock options, excluding diversified mutual funds-Aligos|Stocks or stock options, excluding diversified mutual funds-Livivos|Stocks or stock options, excluding diversified mutual funds-Medicinnova|Stocks or stock options, excluding diversified mutual funds-89bio|Speakers Bureau-AbbVie (Any division)|Speakers Bureau-Gilead Sciences, Inc.|Speakers Bureau-Exelixis, Inc.|Speakers Bureau-Madrigal Pharmaceuticals|Consulting Fee-AbbVie (Any division)|Consulting Fee-Alexion Pharmaceuticals|Consulting Fee-Gilead Sciences, Inc.|Consulting Fee-Altimmune|Consulting Fee-HepaTx|Consulting Fee-Intercept|Consulting Fee-Livivos|Consulting Fee-Madrigal Pharmaceuticals|Consulting Fee-Source Bio

Paul Pockros, MD, FACG
Scripps Clinic
La Jolla , CA

Activity/Course Director

Please download and review the support prospectus for details on what is and what is not included with the various support options:

New Treatments in Chronic Liver Disease 2027 Exhibit & Support Prospectus